Repurposing Therapeutic Drugs for COVID-19: Research Challenges and Opportunities, Hearing Before the Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology, House of Representatives, One Hundred Sixteenth Congress, Second Session, June 19, 2020 [open pdf - 3MB]
This is the June 19, 2020 hearing on "Repurposing Therapeutic Drugs for COVID-19 [coronavirus disease 2019]: Research Challenges and Opportunities," held before the House Subcommittee on Investigations and Oversight of the Committee on Science, Space, and Technology. From the Purpose: "The purpose of the hearing is to explore the scientific foundations behind repurposing existing drugs for the treatment of COVID-19. The Subcommittee will discuss how researchers identify and test approved drugs--developed for other uses--that could lessen the severity of COVID-19 symptoms and the regulatory approval process for the use of these drugs among infected patients. The Subcommittee will also explore how the Federal government conducts oversight and supports research in this area and how these processes have been affected by the current pandemic." Statements, letters, and materials submitted for the record include those of the following: Peter Lurie, James Finigan, Rick Stevens, and Benjamin Rome.
Serial No. 116-74
U.S. Government Publishing Office: http://www.gpo.gov/